TrialMedicine2017

Metronomic oral cyclosphosphamide as third-line systemic treatment or beyond in patients with inoperable locoregionally advanced recurrent or metastatic nasopharyngeal carcinoma.

Victor H F Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.